Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;35(7):1943-1945.
doi: 10.1007/s40620-022-01399-6. Epub 2022 Jul 28.

Antiproteinuric effect of paricalcitol in kidney transplant recipients with severe proteinuria: a prospective cohort study

Carlo Garofalo  1 , Carmine Secondulfo  2 , Luca Apicella  2 , Giancarlo Bilancio  2 , Luca De Nicola  1 , Roberto Minutolo  1 , Silvio Borrelli  1 , Michele Provenzano  3 , Remo Luciani  4 , Vincenzo Bellizzi  5
Affiliations

Antiproteinuric effect of paricalcitol in kidney transplant recipients with severe proteinuria: a prospective cohort study

Carlo Garofalo et al. J Nephrol. 2022 Sep.
No abstract available

Keywords: CKD; Kidney transplant recipients; Paricalcitol; Proteinuria.

PubMed Disclaimer

References

    1. Amer H, Fidler ME, Myslak M et al (2007) Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant 7:2748–2756 - DOI
    1. Roodnat JI, Mulder PG, Rischen-Vos J et al (2001) Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation 72:438–444 - DOI
    1. Fernandez-Fresnedo G, Escallada R, Rodrigo E et al (2002) The risk of cardiovascular disease associated with proteinuria in renal transplant patients. Transplantation 73:1345–1348 - DOI
    1. De Nicola L, Conte G, Russo D et al (2012) Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study. BMC Nephrol 13:150 - DOI
    1. Gonzalez E, Rojas-Rivera J et al (2013) Effects of oral paricalcitol on secondary hyperparathyroidism and proteinuria of kidney transplant patients. Transplantation 95:e49–e52 - DOI

MeSH terms

LinkOut - more resources